Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH
Can-Fite BioPharma宣佈加拿大批准其有關用於減少NASH患者肝脂肪的Se的專利申請
Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH
Can-Fite BioPharma宣佈加拿大批准其有關用於減少NASH患者肝脂肪的Se的專利申請
使用瀏覽器的分享功能,分享給你的好友吧